TradeUP Acquisition Corp. (UPTD) Closes Estrella Biopharma Deal
by Nicholas Alan Clayton on 2023-09-29 at 11:17am

TradeUP (NASDAQ:UPTD) announced this morning that it has closed its combination with Estrella Biopharma and its shares and warrants will begin trading on the Nasdaq under the symbols “ESLA” and “ESLAQ” on October 2.

This will be the first time that TradeUp sub-unit’s will split into shares and their accompanied 1/2 warrants. The SPAC secured shareholder approval for the deal way back on July 31, but TradeUP has spent the past two months securing additional committed financing for the combination.

Estrella is to receive $23.1 million in gross proceeds in the end made up of $10 million in PIPE cash, $9.75 million from a preferred offering and about $300,000 in debt, according to the parties’ press release.

That leaves about $3.05 million in equity coming from TradeUp shares. The SPAC saw 98% redemptions reduce its trust to about $829,703 in the final vote, but it also issued 250,000 TradeUp shares to White Lion Capital as a part of a its commitments in a common stock agreement that may see it purchase up to $50 million in stock post-close.

TradeUp initially announced its $398 million combination with Estrella Biopharma in October 2022. Emeryville, California-based Estrella is developing three potential cancer therapies aimed at improving the effectiveness of T-cell treatments.

In March, it gained FDA clearance to start Phase I/II trials for its EB-103 drug candidate, which uses its CD19 t-cell therapy to combat b-cell lymphoma.


ADVISORS

  • US Tiger Securities, Inc. has acted as financial advisor to TradeUP.
  • Robinson & Cole LLP acted as legal advisor to TradeUP.
  • Winston & Strawn LLP acted as legal advisor to Estrella.
TradeUP Acquisition Corp. (UPTD) Closes Estrella Biopharma Deal
Recent Posts
by Kristi Marvin on 2025-07-05 at 10:02am

Terms Tracker for the Week Ending July 3, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re heading into the July 4th holiday, so we’ll keep this week’s column short and to the point. But before you head to the beach,...

by Nicholas Alan Clayton on 2025-07-03 at 12:54pm

Crown PropTech (OTC:CPTKW) has entered into a definitive agreement to combine with rare earth mining firm Mkango Resources (TSX-V:MKA) at a pre-money equity value of $400 million. London-based Mkango is working to commercialize a chain of rare earth mining and refining facilities in Africa and Europe. The combined company is expected to trade on the...

by Nicholas Alan Clayton on 2025-07-03 at 8:27am

At the SPAC of Dawn One of the biggest sources of uncertainty in the SPAC market in recent years has been regulatory changes, but new shifts could be in its favor. SEC Chairman Paul Atkins told CNBC yesterday that the commission would review the rules for SPACs after “rather controversial” changes to the rules passed...

by Nicholas Alan Clayton on 2025-07-02 at 12:13pm

McKinley Acquisition Corporation (NASDAQ:MKLYU) has filed for a $150 million SPAC to hunt for an innovative target company with an experienced financial team that has dabbled in SPACs before. The new SPAC is offering investors one right to a 1/10 share in each unit with no overfunding of the trust, but it could provide a...

by Nicholas Alan Clayton on 2025-07-02 at 8:29am

At the SPAC of Dawn The rain of SPACs has continued with four expected to make their debuts during today’s trading sessions after pricing their IPOs overnight. The largest of these, EQV Ventures II (NASDAQ:EVACU), even managed an upsize, making it the largest SPAC IPO since Ares II (NYSE:AACT) pulled together $450 million in 2023....

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved